Elbasvir/Grazoprevir in People With Hepatitis C Genotype 1 Infection and Child-Pugh Class B Cirrhosis: The C-SALT Study

Treatment options are limited for people infected with hepatitis C virus (HCV) with decompensated liver disease. The C-SALT study assessed elbasvir (EBR) plus grazoprevir (GZR) in individuals with HCV genotype 1 infection and Child-Pugh class B (CP-B) cirrhosis. METHODS: In this 12-week, phase 2, no...

Descripción completa

Detalles Bibliográficos
Autores principales: Jacobson, Ira M., Poordad, Fred, Firpi-Morell, Roberto, Everson, Gregory T., Verna, Elizabeth C., Bhanja, Sanhita, Hwang, Peggy, Caro, Luzelena, Robertson, Michael, Charles, Edgar D., Platt, Heather
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6493687/
https://www.ncbi.nlm.nih.gov/pubmed/30939489
http://dx.doi.org/10.14309/ctg.0000000000000007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6493687/
https://www.ncbi.nlm.nih.gov/pubmed/30939489
http://dx.doi.org/10.14309/ctg.0000000000000007

Ejemplares similares